|4Feb 20, 4:02 PM ET

Jacobovitz Shalom 4

Research Summary

AI-generated summary

Updated

Clene (CLNN) Director Jacobovitz Receives 4,098-Share Option Award

What Happened

  • Director Shalom Jacobovitz (reported as Jacobovitz Shalom) received a grant of options for 4,098 shares of Clene Inc. common stock on February 19, 2026. The Form 4 shows an acquisition via award (derivative instrument) with no cash paid at grant.
  • Per the filing footnote, the options were granted under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share and vest immediately upon grant. Because this is an option award, no shares were sold or purchased on the open market.

Key Details

  • Transaction date: 2026-02-19 (reported on Form 4 filed 2026-02-20)
  • Grant: options for 4,098 shares; exercise price $4.73 per share; grant reported as $0.00 cash paid at issuance
  • Vesting: options vest immediately (per footnote)
  • Shares owned after transaction: not specified in the filing
  • Filing timeliness: filed one day after the transaction date (no late filing indicated)
  • Footnote: grant made under the Clene Inc. Amended 2020 Stock Plan

Context

  • This was an option grant (a derivative award). Options give the holder the right to buy shares later at the exercise price; they do not represent immediate ownership until exercised and shares issued.
  • Such grants are typically a form of compensation or retention for insiders; they are not the same as an open-market purchase, and do not necessarily indicate immediate buying or selling intent.